REPAIR BIOTECHNOLOGIES
Repair Biotechnologies is a developer of clinical gene and protein therapies intended to focus on the reversal of age-associated thymic atrophy and consequent loss of immune function. The company's platform is committed to developing treatments for ageing and age-related diseases that address the root causes of these conditions, enabling human beings to improve their health span through targeting the causes of age-related diseases and ageing itself.
REPAIR BIOTECHNOLOGIES
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Syracuse, New York, United States
Country:
United States
Website Url:
http://www.repairbiotechnologies.com
Total Employee:
1+
Status:
Active
Contact:
315-299-2407
Total Funding:
2.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
.. Reason Co-Founder and CEO @ Repair Biotechnologies
Co-Founder and CEO
Bill Cherman Co-Founder and Chairman @ Repair Biotechnologies
Co-Founder and Chairman
2018-03-01
Founder
Investors List
Bioverge
Bioverge investment in Seed Round - Repair Biotechnologies
Longevitytech.fund
Longevitytech.fund investment in Seed Round - Repair Biotechnologies
Jim Mellon
Jim Mellon investment in Seed Round - Repair Biotechnologies
SENS Foundation
SENS Foundation investment in Seed Round - Repair Biotechnologies
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Seed Round - Repair Biotechnologies
Emerging Longevity Ventures
Emerging Longevity Ventures investment in Seed Round - Repair Biotechnologies
Thynk Capital, LLC.
Thynk Capital, LLC. investment in Convertible Note - Repair Biotechnologies
Grapeseed.Bio
Grapeseed.Bio investment in Seed Round - Repair Biotechnologies
Newest Events participated
Official Site Inspections
http://www.repairbiotechnologies.com
- Host name: 65.152.197.104.bc.googleusercontent.com
- IP address: 104.197.152.65
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Repair Biotechnologies"
Repair Biotechnologies
Repair Biotechnologies develops the Cholesterol Degrading Platform, a safe approach to treating medical conditions that arise due to localized accumulations of excess cholesterol. In …See details»
Our Company - Repair Biotechnologies
Our initial focus is on reversal of atherosclerosis, the build up of fatty plaques in arteries, and a condition that directly kills more than 25% of humanity via heart attack and stroke. Towards an …See details»
Executive Team - Repair Biotechnologies
Broad experience in management, fundraising, and the research and development of treatments for cardiometabolic disease. Reason is co-founder and CEO of Repair Biotechnologies. He has been an active angel investor in …See details»
Repair Biotechnologies - Crunchbase Company Profile …
Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform. Its platform technology aims to reverse atherosclerosis, familial hypercholesterolemias, and other conditions in which …See details»
Repair Biotechnologies - LinkedIn
Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP)...See details»
RepairBiotechnologies,Inc. - Nature
With its first-in-class Cholesterol Degrading Platform (CDP), Repair Biotechnologies is tackling the root cause of many difficult-to-treat age-related diseases.See details»
Repair Biotechnologies, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Repair Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, 9 news, and 2 literature, Disease Domain:Endocrinology and ...See details»
Repair Biotechnologies - VentureRadar
Website: https://www.repairbiotechnologies.com/ Develops innovative Cholesterol Degrading Platform therapies, enabling specific cell treatment for medical conditions caused by excess …See details»
Repair Biotechnologies Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Repair Biotechnologies. Use the PitchBook Platform to explore the full profile.See details»
Our Science - Repair Biotechnologies
Learn more about the science behind Repair Biotechnologies' Cholesterol Degrading Platform (CDP).See details»
Repair Biotechnologies Demonstrates Rapid Reversal of …
Apr 2, 2024 · Repair Biotechnologies develops gene therapies based on the proprietary Cholesterol Degrading Platform (CDP) that safely break down excess free cholesterol inside …See details»
Repair Biotechnologies and Genevant Sciences to Collaborate to …
Sep 26, 2024 · Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases.See details»
VitaDAO - Repair Biotechnologies - First-in-class Cell Therapy for ...
Repair Biotechnologies is a preclinical-stage biotech company developing a first-in-class universal cell therapy for atherosclerosis. It aims to reduce the risk of cardiovascular events, such as …See details»
Our Pipeline - Repair Biotechnologies
Repair Biotechnologies has a pipeline of drugs for several of the world's most deadliest indications, all based on our innovative Cholesterol Degrading Platform (CDP).See details»
Developing therapies to degrade free cholesterol - Nature
With its first-in-class Cholesterol Degrading Platform (CDP), Repair Biotechnologiesis tackling the root cause of many difficult-to-treat age-related diseases. High cholesterol is linked to...See details»
Repair recruits mRNA-delivery tech for up to $107M
Sep 26, 2024 · Two biotechs are teaming up to deliver cholesterol-busting mRNA to clogged arteries. Syracuse, New York-based Repair Biotechnologies will use Swiss company …See details»
Repair Biotechnologies Raises $2.15M Seed Round to ... - Business …
May 7, 2019 · SYRACUSE, N.Y.-- (BUSINESS WIRE)--Repair Biotechnologies, Inc. announced today $2.15 million in seed venture funding, to accelerate the preclinical development of its …See details»
Scientific Advisory Board - Repair Biotechnologies
Graham Pawelec is an advisor to Repair Biotechnologies, with deep expertise in immunology and oncology. He is currently Professor of Experimental Immunology in… Dr. Karlsberg is board …See details»
News - Repair Biotechnologies
Get the latest news and updates about Repair Biotechnologies' Cholesterol Degrading Platform (CDP)See details»